Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human)

Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human) is a peptide from the insulin receptor substrate 1 containing regulatory tyrosine sites in their unphosphorylated state. The sequence is valuable for studying kinase-substrate recognition and basal conformations. Researchers use it to compare phosphorylated and dephosphorylated forms in signaling assays. Its defined composition supports mechanistic pathway analysis.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: I01007

CAS No:172615-51-9

Synonyms/Alias:Lys-Lys-Insulin Receptor Substrate-1 (891-902) (dephosphorylated) (human), Lys-Lys-IRS-1 (886-897) (dephosphorylated) (mouse), Lys-Lys-IRS-1 (890-901) (dephosphorylated) (rat), IGF1RK Peptide Substrate

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide CDMOEpitope Mapping ServicesCustom Conjugation ServicePeptide Modification ServicesPeptide Synthesis ServicesPeptide Analysis ServicesPeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers